Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E van der Ryst

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
AIDS Research and Human Retroviruses|May 1, 1997
Characterization and titration of an HIV type 1 subtype E chimpanzee challenge stockF Barré-Sinoussi, M C Georges-Courbot, P N Fultz, et al.
Journal of Virology|February 1, 1997
Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in PygmiesR Mahieux, F Ibrahim, P Mauclere, et al.
Clinical Pharmacology and Therapeutics|April 1, 2011
The innate immune response, clinical outcomes, and ex vivo HCV antiviral efficacy of a TLR7 agonist (PF-4878691)M D Fidock, B E Souberbielle, C Laxton, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
AIDS Research and Human Retroviruses|May 1, 1997
Characterization and titration of an HIV type 1 subtype E chimpanzee challenge stockF Barré-Sinoussi, M C Georges-Courbot, P N Fultz, et al.
Journal of Virology|February 1, 1997
Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in PygmiesR Mahieux, F Ibrahim, P Mauclere, et al.
Clinical Pharmacology and Therapeutics|April 1, 2011
The innate immune response, clinical outcomes, and ex vivo HCV antiviral efficacy of a TLR7 agonist (PF-4878691)M D Fidock, B E Souberbielle, C Laxton, et al.
Pageof 5